atorvastatin has been researched along with Pulmonary Fibrosis in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 7 (87.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Atahan, E; Kayalar, O; Oztay, F; Yildirim, M | 1 |
Buendía, JA; Justinico Castro, JA; Sánchez Villamil, JP; Sinisterra, D; Vela, LJT; Zuluaga Salazar, AF | 1 |
El-Mohandes, EM; Hassan, YF; Khalaf, HA; Moustafa, AM | 1 |
Du, J; Meng, X; Wang, J; Wang, R; Xie, H; Zhou, Z; Zhu, Y | 1 |
Bolkent, S; Karatug Kacar, A; Oztay, F; Yildirim, M | 1 |
Khoramjouy, M; Malekinejad, H; Mehrabi, M; Rezaei-Golmisheh, A | 1 |
Dang, XM; Ma, AQ; Yang, L; Zhu, B | 1 |
Dong, Y; Li, ZH; Wei, LQ | 1 |
8 other study(ies) available for atorvastatin and Pulmonary Fibrosis
Article | Year |
---|---|
Atorvastatin attenuates pulmonary fibrosis in mice and human lung fibroblasts, by the regulation of myofibroblast differentiation and apoptosis.
Topics: Animals; Apoptosis; Atorvastatin; beta Catenin; Bleomycin; Cell Differentiation; Fibroblasts; Humans; Lung; Mice; Mice, Inbred C57BL; Myofibroblasts; Pulmonary Fibrosis; Transforming Growth Factor beta | 2022 |
Comparison of four pharmacological strategies aimed to prevent the lung inflammation and paraquat-induced alveolar damage.
Topics: Animals; Antioxidants; Ascorbic Acid; Atorvastatin; Cyclophosphamide; Dexamethasone; Drug Therapy; Drug Therapy, Combination; Heparin; Heparin, Low-Molecular-Weight; Lung; Paraquat; Pneumonia; Pulmonary Alveoli; Pulmonary Fibrosis; Rats, Wistar; Treatment Outcome | 2019 |
The role of mast cells and macrophages in amiodarone induced pulmonary fibrosis and the possible attenuating role of atorvastatin.
Topics: Amiodarone; Animals; Atorvastatin; Immunohistochemistry; Macrophages; Male; Mast Cells; Pulmonary Fibrosis; Rats; Reference Standards; Staining and Labeling | 2017 |
Atorvastatin attenuates paraquat poisoning-induced epithelial-mesenchymal transition via downregulating hypoxia-inducible factor-1 alpha.
Topics: A549 Cells; Animals; Atorvastatin; Cadherins; Cell Line; Epithelial-Mesenchymal Transition; Humans; Hypoxia; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Lung; Lung Injury; Male; Paraquat; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Signal Transduction; Zonula Occludens-1 Protein | 2018 |
The effects of atorvastatin on the kidney injury in mice with pulmonary fibrosis.
Topics: Animals; Atorvastatin; Bleomycin; Cell Proliferation; Disease Models, Animal; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Pulmonary Fibrosis; Signal Transduction | 2019 |
Antifibrotic effect of atorvastatin on paraquat-induced pulmonary fibrosis: role of PPARγ receptors.
Topics: Anilides; Animals; Atorvastatin; Body Weight; Heptanoic Acids; Herbicides; Hydroxyproline; Lung; Male; Organ Size; Paraquat; Pioglitazone; PPAR gamma; Protective Agents; Pulmonary Fibrosis; Pyrroles; Rats; Rats, Wistar; RNA, Messenger; Thiazolidinediones; Transforming Growth Factor beta1 | 2013 |
Atorvastatin attenuates bleomycin-induced pulmonary fibrosis via suppressing iNOS expression and the CTGF (CCN2)/ERK signaling pathway.
Topics: Animals; Atorvastatin; Bleomycin; Body Weight; Collagen; Connective Tissue Growth Factor; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hydroxyproline; Male; Malondialdehyde; Nitric Oxide; Nitric Oxide Synthase Type II; Phosphorylation; Pulmonary Fibrosis; Pyrroles; Rats; Rats, Sprague-Dawley; Signal Transduction | 2013 |
[Effect of atorvastatin on MMP-9 and TIMP-1 levels in bronchoalveolar lavage fluid and serum of rats with bleomycin-induced pulmonary fibrosis].
Topics: Animals; Atorvastatin; Bleomycin; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Female; Heptanoic Acids; Matrix Metalloproteinase 9; Pulmonary Fibrosis; Pyrroles; Rats; Rats, Wistar; Tissue Inhibitor of Metalloproteinase-1 | 2011 |